Clinical Trial: A Phase 2 Study of MZE782 in Adults With PKU

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07694440) titled 'A Phase 2 Study of MZE782 in Adults With PKU' on July 02.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).

Study Start Date: June 23

Study Type: INTERVENTIONAL

Condition: Phenylketonuria (PKU)

Intervention: DRUG: MZE782

Tablet, Low Dose

OTHER: Placebo

Tablet

DRUG: MZE782

Tablet, High Dose

Recruitment Status: RECRUITING

Sponsor: Maze Therapeutics

Published by HT Digital Content Services with permission from Health Daily Digest....